Good evening :)
Switch to
Place Order

Kilitch Drugs (India) Ltd

KILITCH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹245 cr, stock is ranked 1,418
High RiskStock is 3.12x as volatile as Nifty
157.651.05 (-0.66%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹245 cr, stock is ranked 1,418
High RiskStock is 3.12x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
67.03
PB RatioPB Ratio
2.04
Dividend YieldDiv. Yield
Sector PESector PE
38.17
Sector PBSector PB
5.69
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Kilitch Drugs (India) Limited is engaged in the development and operations of pharmaceutical business. The Company's services range from manufacturing to marketing a host of formulations in solid, liquid and parenteral forms.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202153.8986.4957.4571.195.153.820.833.66
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Financial Result Updates 
Announced OnJun 22, 2021

Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021. | Download

Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021. | Download

Outcome of Board Meeting 
Announced OnJun 22, 2021

Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on Jun 22, 2021. | Download

Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on Jun 22, 2021. | Download

Cash Dividend 
Ex. DateSep 20, 2019

Final • Div/Share: ₹ 0.5

See all events